Skip to content
Home/Companies/MedTech/Autonomic Technologies

Autonomic Technologies

MedTech·US·Exited 2020·Held 5yr
Entry
2015
Hold
5yr
Exit
2020

Who owns Autonomic Technologies?

Autonomic Technologies was owned by Andera Partners through BioDiscovery 4 (2013 vintage) from 2015 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 4 · 2013 · VC

Key facts

HQUnited States
SectorMedTech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from BioDiscovery 4

Other portfolio companies in the same fund.

Inotrem
Active
BiotechFrance
MedDay Pharmaceuticals
Exited 2021
BiotechFrance· 2016
Verona Pharma
Verona Pharma
Exited 2017
BiotechUK· 2016
Gamamabs
Active
BiotechFrance· 2015
ReViral
Exited 2022
BiotechUK· 2015
to
Sanifit
Exited 2021
BiotechSpain· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Autonomic Technologies

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Autonomic Technologies?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Autonomic Technologies.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue